Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Alkermes (ALKS) EBIT (2016 - 2025)

Historic EBIT for Alkermes (ALKS) over the last 16 years, with Q3 2025 value amounting to $89.1 million.

  • Alkermes' EBIT fell 1496.24% to $89.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $358.5 million, marking a year-over-year increase of 1470.38%. This contributed to the annual value of $420.6 million for FY2024, which is 157.3% up from last year.
  • According to the latest figures from Q3 2025, Alkermes' EBIT is $89.1 million, which was down 1496.24% from $93.0 million recorded in Q2 2025.
  • Alkermes' 5-year EBIT high stood at $281.3 million for Q2 2023, and its period low was -$60.6 million during Q3 2022.
  • Moreover, its 5-year median value for EBIT was $54.6 million (2023), whereas its average is $59.1 million.
  • As far as peak fluctuations go, Alkermes' EBIT plummeted by 87939.38% in 2022, and later skyrocketed by 91628.99% in 2023.
  • Alkermes' EBIT (Quarter) stood at $129.4 million in 2021, then decreased by 10.68% to $115.6 million in 2022, then plummeted by 52.74% to $54.6 million in 2023, then soared by 197.79% to $162.7 million in 2024, then tumbled by 45.24% to $89.1 million in 2025.
  • Its last three reported values are $89.1 million in Q3 2025, $93.0 million for Q2 2025, and $13.8 million during Q1 2025.